News

CNET13h
Will I Have to Pay for a COVID Vaccine and How Much Will It Cost?
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
Moderna’s new, lower-dose COVID-19 vaccine gets approved by the FDA
The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
kffhealthnews1d
Missed Deadline: Novavax’s Covid Shot Still Awaiting FDA’s Full Approval
The Wall Street Journal: FDA Punts On Major Covid-19 Vaccine Decision After Ouster Of Top Official Federal drug regulators have missed the deadline for making a key decision regarding a Covid-19 ...
Rheumatology Advisor3d
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.
Zacks Investment Research on MSN6d
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...